Search results for: 'api infrastructure development access adas'

15 Nov 2021  |  North America  |  Market Research

US Military Electric Vertical Take-off and Landing (eVTOL) Aircraft Growth Opportunities

Advances in Potential Military Applications Increase Interest in the Commercial eVTOL Industry

Infographics

×

The necessity of developing green fuel for aircraft and airlines drives the development of the electric vertical take-off landing aircraft (eVTOL) commercial industry. Market participants are pursuing eVTOL development to produce a quiet and cost-effective air taxi. In this report, Frost & Sullivan details the US Department of Defense’s (DoD) ...

For a long time, drug discovery followed the same path and used conventional analysis methods for proposed targets. Today, changes in technology and the ability to study omics are transforming drug development. Personalized therapy is on the rise and promises to be more effective and efficient in addressing challenges. With growing interest in ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides innovation insights across cell and gene therapy advances. The TOE also encompasses recent therapy developments for neuropsychiatric, rare, and infectious diseases. The research covers recent advances in vaccines and biomanufacturing platforms.The Life ...

19 Aug 2022  |  North America  |  Market Research

Global Antibody Therapeutics Growth Opportunities

The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

Infographics

×

Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

29 Jun 2023  |  Global  |  Technology Research

Emerging Landscape of Targeted Protein Degradation Therapeutics

Rapid Technology Advances Bolster a Robust Therapeutic Pipeline

Infographics

×

This Frost & Sullivan research report provides an in-depth analysis of the emerging targeted protein degradation (TPD) space. TPD strategies enable treating various diseases not yet treatable via conventional approaches by attacking disease-causing proteins in a controlled manner, thus reducing the risk of side effects. It is estimated that 80%...

This research service explores the market trends surrounding the growth of zero-latency systems. With an exponential increase in the volume of online activity and the resultant explosion in the amount of data being generated, the speed and reliability of networks have become crucial. This has resulted in an increase in the demand for the developmen...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provide insights across new biologics, and precision cancer therapy innovations. The research also comprises small molecule, cell and gene therapy and gene editing advancements for Niemann–Pick Disease and autoimmune diseases.The Life Science, Health & Wellness ...

11 Nov 2022  |  North America  |  Market Research

Global Contract Research Organization (CRO) Growth Opportunities

Strong Competitive Intensity is Mandating a Greater Industry Convergence Resulting in a Strong Market Growth

Infographics

×

Key Issues Addressed

The COVID-19 pandemic led to a sudden surge in R&D activities across the world. Both small and large pharmaceutical and biotech companies were engaged in tremendous efforts to either develop new molecules or repurpose existing therapies as potential drugs for COVID-19 treatment. The trend is likely to continue with small-to-medium-segment and e...

Small molecules, which are the leading drug class across indications, face several issues that threaten their drug delivery efficacy. They suffer from off-target effects, poor bioavailability, low solubility, systemic toxicity, and poor permeability. While the small molecule drug development pipeline remains a leading therapeutic class, it is essen...